5 Stocks To Gain From Medical Device Excise Tax Exemption

Orthofix International N.V. (OFIX - Snapshot Report): Orthofix is a Curacao-based medical device provider of reconstructive and regenerative orthopedic and spine solutions across the globe. This Zacks Rank #1 company currently holds a market cap of $759.03 million and has seen 5.63% surge in its share price in the past 12 weeks. 

While the company’s cash flow per share is 2.02, compared to the industry average of 0.00; its projected EPS growth for the current year is 67.1% compared to the industry average of 10.1%. Over the long term, Orthofix’s expected EPS growth rate is 16.2%.

Anika Therapeutics Inc. (ANIK - Snapshot Report): Massachusetts-based Anika Therapeutics is a pioneer in developing hyaluronic acid (HA)-based therapeutic products for tissue protection, wound healing and repair. This Zacks Rank #1 company currently holds a market cap of $668.85 million and has witnessed an 18.61% gain in its share price over the past 12 weeks.

While its current earnings yield is 3.92%, far better than the industry average of -9.82%; its return on equity is 15.71% compared to the industry average of -21.6%. Over the long term, the company’s expected EPS growth rate is pegged at 15%.

Computer Programs & Systems Inc. (CPSI - Snapshot Report): Alabama-based, Computer Programs & Systems provides healthcare information technology solutions for rural and community hospitals in the U.S. This Zacks Rank #1 company currently holds a market cap of $726.85 million and has gained 11.78% on the bourse in the past 12 weeks. 

While its current earnings yield is 6.32%, compared to the industry average of -3.45%; its projected EPS growth for current year is 113.7% as against the industry average of 11.7%. Over the long term, the company’s expected EPS growth rate is 14%.

Invitae Corporation (NVTA - Snapshot Report): California-based Invitae is a genetic information company, which provides genetic diagnostics for various hereditary disorders. This Zacks Rank #2 company currently holds a market cap of $283.82 million and has witnessed a massive 283.8% hike in its stock price in the past 12 weeks. While its projected sales growth is 334.15% as against the industry average of 19.09%; its projected EPS growth for the current year is 12.26% versus the industry average of 11.67%. Over the long term, the company’s expected EPS growth rate is pegged at 14%.

View single page >> |

more

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.